Source:http://linkedlifedata.com/resource/pubmed/id/20053516
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-2-1
|
pubmed:abstractText |
The purpose of the present work was developing an in vitro dissolution test to highlight the possible molecular background causing ciprofloxacin (CPFX)-milk interaction. The in vitro dissolution of CPFX from film-coated tablets (Ciprinol) 500mg) was examined at different pH values, simulating certain parts of the gastrointestinal tract, in the presence of water, low-fat milk, casein- or calcium enriched water. In order to determine the amount of dissolved CPFX, solid phase extraction sample preparation followed by high performance liquid chromatography coupled with mass spectrometry was applied. Comparing the dissolution efficiency values in various media, it can be concluded, that casein has a more pronounced effect on the absorbable amount of the antibiotic at each pH value studied, than calcium. In the case of concomitant intake of CPFX film-coated tablet and milk or other dairy products not only the complexation with calcium, but also the adsorption of CPFX on the surface of proteins decreases the absorbable amount of CPFX.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Caseins,
http://linkedlifedata.com/resource/pubmed/chemical/Ciprofloxacin,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Tablets
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1873-264X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2009 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37-42
|
pubmed:dateRevised |
2010-7-23
|
pubmed:meshHeading |
pubmed-meshheading:20053516-Animals,
pubmed-meshheading:20053516-Anti-Infective Agents,
pubmed-meshheading:20053516-Biological Availability,
pubmed-meshheading:20053516-Calcium,
pubmed-meshheading:20053516-Caseins,
pubmed-meshheading:20053516-Chromatography, High Pressure Liquid,
pubmed-meshheading:20053516-Ciprofloxacin,
pubmed-meshheading:20053516-Food-Drug Interactions,
pubmed-meshheading:20053516-Hydrogen-Ion Concentration,
pubmed-meshheading:20053516-Kinetics,
pubmed-meshheading:20053516-Lipids,
pubmed-meshheading:20053516-Milk,
pubmed-meshheading:20053516-Reproducibility of Results,
pubmed-meshheading:20053516-Solid Phase Extraction,
pubmed-meshheading:20053516-Solubility,
pubmed-meshheading:20053516-Spectrometry, Mass, Electrospray Ionization,
pubmed-meshheading:20053516-Tablets
|
pubmed:year |
2010
|
pubmed:articleTitle |
In vitro food-drug interaction study: Which milk component has a decreasing effect on the bioavailability of ciprofloxacin?
|
pubmed:affiliation |
Semmelweis University, Department of Pharmaceutics, Hogyes E. Str. 7, H-1092 Budapest, Hungary.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|